跳至主要内容
临床试验/NCT04513847
NCT04513847已完成不适用

PsoVac: A Psoriatic Patient-based Survey on the Understanding of the Use of Vaccines While on Biologics During the Covid-19 Pandemic

Dermatrials Research1 个研究点 分布在 1 个国家目标入组 661 人开始时间: 2020年8月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
661
试验地点
1
主要终点
Percentage of patients not understanding the interaction of vaccines and their biologic, assessed with voluntary survey.

研究概览

简要总结

To determine if there is a need for further education on vaccines with psoriasis patients who are on a biologic. In regards to the COVID-19, it is important that psoriasis patients - whether on a biologic or not - understand whether they can have certain vaccines. That will depend on the type of vaccine that becomes available.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • psoriasis patient

排除标准

  • no exclusions

结局指标

主要结局

Percentage of patients not understanding the interaction of vaccines and their biologic, assessed with voluntary survey.

时间窗: Data will be collected over a span of 3 months

Assessment is based upon survey responses. By answering multiple questions we will determine if more education is needed based on the answers.

次要结局

未报告次要终点

研究者

发起方
Dermatrials Research
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ronald Vender MD FRCPC

Associate Clinical Professor, Division of Dermatology MD FRCPC

Dermatrials Research

研究点 (1)

Loading locations...

相似试验